Diabetes Mellitus, Type 2
Conditions
Keywords
Adults, dialogue tools, outpatient clinic visits
Brief summary
EMMA: Empowerment, Motivation and Medical Adherence. A consultation program based on dialogue tools for adults with poorly regulated Type 2 diabetes.
Detailed description
Traditionally, the success of patients to manage their diabetes has been judged by their ability to adhere to a prescribed therapeutic regimen, and efforts have been spent developing strategies to promote adherence. It is estimated that 20% to 50% of patients with chronic conditions are not adherent to their prescribed medication regimen, with non-adherence being defined as \<80% adherence to prescribed, relevant medication. The treatment regimen often comprises several elements such as poly-pharmacy including insulin administration, self-monitoring of blood glucose, diet and physical exercise. It is thus not just a matter of 'taking a pill or not' but implies lifestyle changes, knowledge and competence, and internal motivation for self-management. The investigators developed a consultation program based on dialogue tools. The EMMA program aims to support medication adherence and blood glucose control by facilitating rapport, exploring patient concerns and challenges, enabling knowledge exchange and supporting goal-setting and action-planning. A pilot test of the program appeared feasible and acceptable to patients and health care professionals and showed significant decrease on HbA1c. EMMA is now ready to be tested in a randomized controlled study (RCT) study.
Interventions
BEHAVIORALEMMA
Consultations using dialogue tools
Sponsors
Steno Diabetes Center Copenhagen
Study design
Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Adults Type 2 diabetes ≥ 18 år * Type 2 diabetes ≥ 1 år * HbA1c ≥ 64 mmol/mol (≥ 8%) at the last three measures before randomisation * Taking medication for Type 2 diabetes • - Speak, read and understands Danish
Exclusion criteria
* Participating in other intervention research projects during the trial period * Being treated by a psychiatrist or psychologist during the period * Reduced sight or blindness
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| HbA1c | Baseline, 4½ month and 6 months after end of intervention period | Change from baseline in HbA1c at 4½ month which is maintained or improved at 6 months |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Self-management | Baseline, 4½ month and 6 months after end of intervention period | Change from baseline in Self-management skills at 4½ month assessed by increase in the Perceived Competence In Diabetes (PCD scale) which is maintained or improved at 6 months |
Countries
Denmark
Contacts
Primary ContactGitte R Husted, PhD
Backup ContactBjarne B Jensen, Professor
Outcome results
None listed